MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3

Integrin-Associated CD151 Drives ErbB2-Evoked Mammary Tumor Onset and Metastasis

(2015) Xinyu Deng et al.   NEOPLASIA

Netrin-4 Promotes Glioblastoma Cell Proliferation through Integrin β4 Signaling

(2015) Yizhou Hu et al.   NEOPLASIA

Down-Regulation of the miRNA-200 Family at the Invasive Front of Colorectal Cancers with Degraded Basement Membrane Indicates EMT Is Involved in Cancer Progression

(2015) Emily L. Paterson et al.   NEOPLASIA

MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer

(2014) Min-Xia Liu et al.   Molecular Cancer

Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin β1

(2014) Yanyang Zhao et al.   PLoS One

Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin β1 in Hepatocellular Carcinoma

(2014) Ruopeng Zha et al.   PLoS One

MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome

(2013) Yoshitsugu Mitani et al.   PLoS One

MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin

(2012) Jian-Yong Sun et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

(2011) Jingqi Chen et al.   CANCER CELL

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

(2011) L Sun et al.   ONCOGENE

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

(2010) F Yu et al.   ONCOGENE

Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma

(2010) Yaling Tang et al.   ORAL ONCOLOGY

MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor

(2009) J. Li et al.   CLINICAL CANCER RESEARCH

miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation

(2009) Dale G. Schaar et al.   EXPERIMENTAL HEMATOLOGY

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

(2009) Ulrich Wellner et al.   NATURE CELL BIOLOGY

Serum MicroRNAs Are Promising Novel Biomarkers

(2008) Shlomit Gilad et al.   PLoS One

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA